Guo-liang Yu, Ph.d.
EXECUTIVE CHAIRMAN AND CHIEF TECHNOLOGY OFFICER
general science
Crown BioScience
United States of America
Biography
Dr. Yu co-founded Epitomics Inc., an antibody based Biotechnology Company recently acquired by Abcam for $170M. He served as Chairman, President, and CEO of Epitomics Inc. for 10 years. Dr. Yu's success is driven by his scientific curiosity and a passion for translating scientific discovery to real products. His challenge is to balance his time between science and business, fun and work, family and community.
Research Interest
Journal of Astrobiology & Outreach [jao] Entomology, Ornithology & Herpetology: Current Research [eohcr] Journal of Biomusical Engineering [jbe] Forest Research: Open Access [jfor] Journal of Ergonomics [jer]
